UPDATE: Nomura Initiates Cavium at Reduce on Share Overvalue
In a report published Tuesday, Nomura analyst Sanjay Chaurasia initiated coverage on Cavium (NASDAQ: CAVM) with a Reduce rating and $28.00 price target.
In the report, Nomura noted, “Cavium trades at a 75% premium to its comp group and is the most expensive name in our coverage. Investors assign a premium owing to Cavium's past revenue performance, positioning at key accounts, and high expectations from Neuron and Project Thunder. However, our analysis suggests that investors may be overvaluing the shares given recent weakness in enterprise security and app acceleration, as well as challenges in 2014 (Broadcom competition and lack of exposure to wireless infrastructure spending. We forecast CY13/CY14 sales/EPS of $296mn/$0.90 and $340mn/$1.15 vs. consensus of $307mn/$0.97 and $372mn/$1.34.”
Cavium closed on Monday at $37.41.
Latest Ratings for CAVM
|Sep 2016||Susquehanna||Initiates Coverage on||Positive|
|Sep 2016||JP Morgan||Assumes||Overweight|
© 2016 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.